ArticleJournal of gastroenterology2014

Once-daily simeprevir in combination with pegylated-interferon and ribavirin: a new horizon in the era of direct-acting antiviral agent therapy for chronic hepatitis C.

Shinya Maekawa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.